AC Immune
ACIU
17 hedge funds and large institutions have $90.4M invested in AC Immune in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.35% less ownership
Funds ownership: 18.41% → 18.06% (-0.35%)
6% less funds holding
Funds holding: 18 → 17 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
70% less capital inflows, than outflows
Capital inflows: $923K | Capital outflows: $3.03M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBC
Lawrence B. Cohen
|
+$312K |
| 2 |
Renaissance Technologies
New York
|
+$186K |
| 3 |
Goldman Sachs
New York
|
+$134K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$128K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$58.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.27M |
| 2 |
GSA Capital Partners
London,
United Kingdom
|
-$525K |
| 3 |
ALPS Advisors
Denver,
Colorado
|
-$485K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$325K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$277K |
ACIU Hedge Fund Activity: Q2 2017 in Review
17 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2017, worth a combined $90.4M — down 17% from $109M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACIU and 6 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Lawrence B. Cohen, opening a new position worth an estimated $312K. The largest seller was Millennium Management, exiting entirely with an estimated $1.27M sold.
- 17 institutional investors held AC Immune (ACIU) as of Q2 2017, down from 18 in Q1 2017.
- Funds reported $90.4M of AC Immune stock for Q2 2017, down 17% quarter-over-quarter.
- 6 funds opened new AC Immune positions in Q2 2017 and 7 closed out, a net change of -1 holder.
- The largest AC Immune buyer in Q2 2017 was Lawrence B. Cohen, an estimated $312K added.
- The largest AC Immune seller in Q2 2017 was Millennium Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q2 2017.